TWD 53.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 355.04 Million TWD | -9.23% |
2022 | 391.14 Million TWD | -6.03% |
2021 | 416.23 Million TWD | 1.23% |
2020 | 411.18 Million TWD | -22.91% |
2019 | 533.36 Million TWD | 7.13% |
2018 | 484.12 Million TWD | 55.39% |
2017 | 329.38 Million TWD | -3.29% |
2016 | 329.32 Million TWD | 17.96% |
2015 | 281.07 Million TWD | 50.52% |
2014 | 184.38 Million TWD | 20.46% |
2013 | 257.98 Million TWD | 23.84% |
2012 | 135.46 Million TWD | -15.58% |
2011 | 145.46 Million TWD | 10.34% |
2010 | 136.68 Million TWD | 29.43% |
2009 | 116.7 Million TWD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 69.5 Million TWD | -22.06% |
2024 Q2 | 87.77 Million TWD | 26.28% |
2023 Q3 | 88.9 Million TWD | -5.49% |
2023 Q4 | 89.17 Million TWD | 0.3% |
2023 FY | - TWD | -9.23% |
2023 Q1 | 100.46 Million TWD | 22.59% |
2023 Q2 | 94.07 Million TWD | -6.37% |
2022 Q4 | 81.95 Million TWD | -20.66% |
2022 FY | - TWD | -6.03% |
2022 Q1 | 121.98 Million TWD | 27.12% |
2022 Q2 | 83.91 Million TWD | -31.21% |
2022 Q3 | 103.29 Million TWD | 23.1% |
2021 Q3 | 110.19 Million TWD | 38.51% |
2021 FY | - TWD | 1.23% |
2021 Q1 | 142.55 Million TWD | 55.67% |
2021 Q2 | 79.55 Million TWD | -44.19% |
2021 Q4 | 95.96 Million TWD | -12.92% |
2020 Q1 | 106.83 Million TWD | 27.92% |
2020 Q4 | 91.57 Million TWD | -2.83% |
2020 FY | - TWD | -22.91% |
2020 Q3 | 94.24 Million TWD | -20.49% |
2020 Q2 | 118.52 Million TWD | 10.95% |
2019 Q4 | 83.51 Million TWD | -19.06% |
2019 FY | - TWD | 7.13% |
2019 Q3 | 103.18 Million TWD | -34.9% |
2019 Q2 | 158.49 Million TWD | -15.77% |
2019 Q1 | 188.17 Million TWD | 7.74% |
2018 Q2 | 90.5 Million TWD | 9.51% |
2018 FY | - TWD | 55.39% |
2018 Q1 | 82.64 Million TWD | 0.35% |
2018 Q4 | 174.64 Million TWD | 16.38% |
2018 Q3 | 150.06 Million TWD | 65.82% |
2017 FY | - TWD | -3.29% |
2017 Q1 | 78.59 Million TWD | 1.0% |
2017 Q3 | 87.66 Million TWD | 22.13% |
2017 Q4 | 82.35 Million TWD | -6.06% |
2017 Q2 | 71.77 Million TWD | -8.67% |
2016 Q1 | 77.7 Million TWD | -4.51% |
2016 Q4 | 77.81 Million TWD | -14.14% |
2016 Q2 | 85.11 Million TWD | 9.53% |
2016 Q3 | 90.63 Million TWD | 6.48% |
2016 FY | - TWD | 17.96% |
2015 Q2 | 62.32 Million TWD | 1.62% |
2015 FY | - TWD | 50.52% |
2015 Q4 | 81.37 Million TWD | 7.36% |
2015 Q3 | 75.79 Million TWD | 21.61% |
2015 Q1 | 61.33 Million TWD | -4.02% |
2014 Q2 | 41.51 Million TWD | 11.22% |
2014 Q1 | 37.32 Million TWD | -12.81% |
2014 FY | - TWD | 20.46% |
2014 Q4 | 63.9 Million TWD | 45.8% |
2014 Q3 | 43.83 Million TWD | 5.59% |
2013 Q4 | 42.81 Million TWD | 4.29% |
2013 Q2 | 33.71 Million TWD | -9.66% |
2013 Q1 | 37.31 Million TWD | 22.8% |
2013 FY | - TWD | 23.84% |
2013 Q3 | 41.04 Million TWD | 21.76% |
2012 Q1 | 33.79 Million TWD | -40.11% |
2012 Q4 | 30.39 Million TWD | -15.07% |
2012 FY | - TWD | -15.58% |
2012 Q3 | 35.78 Million TWD | 44.27% |
2012 Q2 | 24.8 Million TWD | -26.6% |
2011 Q2 | 24.17 Million TWD | -24.16% |
2011 Q1 | 31.87 Million TWD | -10.56% |
2011 Q4 | 56.42 Million TWD | 58.1% |
2011 Q3 | 35.68 Million TWD | 47.63% |
2011 FY | - TWD | 10.34% |
2010 Q3 | 39.84 Million TWD | 54.63% |
2010 Q2 | 25.76 Million TWD | -21.98% |
2010 FY | - TWD | 29.43% |
2010 Q1 | 33.02 Million TWD | 0.0% |
2010 Q4 | 35.63 Million TWD | -10.56% |
2009 FY | - TWD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Mao Bao Inc. | 9.01 Million TWD | -3838.425% |
Taiyen Biotech Co., Ltd. | 518.26 Million TWD | 31.493% |
Sanitar Co., Ltd. | 401.77 Million TWD | 11.63% |
Chlitina Holding Limited | 1.96 Billion TWD | 81.966% |
Jourdeness Group Limited | 802.68 Million TWD | 55.767% |
Nan Liu Enterprise Co., Ltd. | 798.8 Million TWD | 55.552% |
Luo Lih-Fen Holding Co., Ltd. | 120.7 Million TWD | -194.146% |
San Neng Group Holdings Co., Ltd. | 336.41 Million TWD | -5.539% |
Yuen Foong Yu Consumer Products Co., Ltd. | 1.67 Billion TWD | 78.753% |
KNH Enterprise Co., Ltd. | 1.41 Billion TWD | 74.918% |